Annual EBIT
-$12.57 M
-$16.40 M-427.92%
31 December 2023
Summary:
Cytek Biosciences annual earnings before interest & taxes is currently -$12.57 million, with the most recent change of -$16.40 million (-427.92%) on 31 December 2023. During the last 3 years, it has fallen by -$27.33 million (-185.14%). CTKB annual EBIT is now -185.14% below its all-time high of $15.37 million.CTKB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$276.00 K
+$7.33 M+103.91%
30 September 2024
Summary:
Cytek Biosciences quarterly earnings before interest & taxes is currently $276.00 thousand, with the most recent change of +$7.33 million (+103.91%) on 30 September 2024. Over the past year, it has increased by +$3.87 million (+107.69%). CTKB quarterly EBIT is now -96.69% below its all-time high of $8.33 million, reached on 31 December 2020.CTKB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$10.82 M
+$3.87 M+26.32%
30 September 2024
Summary:
Cytek Biosciences TTM earnings before interest & taxes is currently -$10.82 million, with the most recent change of +$3.87 million (+26.32%) on 30 September 2024. Over the past year, it has increased by +$2.52 million (+18.88%). CTKB TTM EBIT is now -155.62% below its all-time high of $19.46 million, reached on 30 June 2021.CTKB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -427.9% | +107.7% | +18.9% |
| 3 y3 years | -185.1% | -89.0% | -171.8% |
| 5 y5 years | - | - | - |
CTKB EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -185.1% | at low | -94.3% | +103.2% | -171.8% | +26.3% |
| 5 y | 5 years | -185.1% | +22.9% | -96.7% | +103.2% | -155.6% | +26.3% |
| alltime | all time | -185.1% | +22.9% | -96.7% | +103.2% | -155.6% | +26.3% |
Cytek Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $276.00 K(-103.9%) | -$10.82 M(-26.3%) |
| June 2024 | - | -$7.05 M(-17.5%) | -$14.69 M(+6.3%) |
| Mar 2024 | - | -$8.55 M(-289.8%) | -$13.82 M(+1.4%) |
| Dec 2023 | -$12.57 M(-427.9%) | $4.50 M(-225.5%) | -$13.64 M(+2.2%) |
| Sept 2023 | - | -$3.59 M(-42.0%) | -$13.34 M(+84.0%) |
| June 2023 | - | -$6.19 M(-26.1%) | -$7.25 M(+298.3%) |
| Mar 2023 | - | -$8.37 M(-274.3%) | -$1.82 M(-147.5%) |
| Dec 2022 | $3.83 M | $4.80 M(+92.1%) | $3.83 M(<-9900.0%) |
| Sept 2022 | - | $2.50 M(-431.4%) | -$32.00 K(+113.3%) |
| June 2022 | - | -$754.00 K(-72.2%) | -$15.00 K(-100.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.71 M(-389.9%) | $4.44 M(-42.2%) |
| Dec 2021 | $7.68 M(-48.0%) | $936.00 K(-62.8%) | $7.68 M(-49.1%) |
| Sept 2021 | - | $2.52 M(-32.0%) | $15.07 M(-22.5%) |
| June 2021 | - | $3.70 M(+602.1%) | $19.46 M(+22.0%) |
| Mar 2021 | - | $527.00 K(-93.7%) | $15.95 M(+8.0%) |
| Dec 2020 | $14.76 M(-190.6%) | $8.33 M(+20.8%) | $14.76 M(+129.6%) |
| Sept 2020 | - | $6.90 M(+3474.6%) | $6.43 M(-1474.1%) |
| June 2020 | - | $193.00 K(-129.2%) | -$468.00 K(-29.2%) |
| Mar 2020 | - | -$661.00 K | -$661.00 K |
| Dec 2019 | -$16.29 M | - | - |
FAQ
- What is Cytek Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cytek Biosciences?
- What is Cytek Biosciences annual EBIT year-on-year change?
- What is Cytek Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cytek Biosciences?
- What is Cytek Biosciences quarterly EBIT year-on-year change?
- What is Cytek Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cytek Biosciences?
- What is Cytek Biosciences TTM EBIT year-on-year change?
What is Cytek Biosciences annual earnings before interest & taxes?
The current annual EBIT of CTKB is -$12.57 M
What is the all time high annual EBIT for Cytek Biosciences?
Cytek Biosciences all-time high annual earnings before interest & taxes is $15.37 M
What is Cytek Biosciences annual EBIT year-on-year change?
Over the past year, CTKB annual earnings before interest & taxes has changed by -$16.40 M (-427.92%)
What is Cytek Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of CTKB is $276.00 K
What is the all time high quarterly EBIT for Cytek Biosciences?
Cytek Biosciences all-time high quarterly earnings before interest & taxes is $8.33 M
What is Cytek Biosciences quarterly EBIT year-on-year change?
Over the past year, CTKB quarterly earnings before interest & taxes has changed by +$3.87 M (+107.69%)
What is Cytek Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of CTKB is -$10.82 M
What is the all time high TTM EBIT for Cytek Biosciences?
Cytek Biosciences all-time high TTM earnings before interest & taxes is $19.46 M
What is Cytek Biosciences TTM EBIT year-on-year change?
Over the past year, CTKB TTM earnings before interest & taxes has changed by +$2.52 M (+18.88%)